TechInvest

03/01/2025

Weebit Nano (ASX: WBT) has entered 2025 on a high note, announcing a major licensing agreement with US semiconductor giant onsemi (NASDAQ: ON). The deal underscores the growing industry recognition of Weebit Nano’s resistive random access memory (ReRAM) technology as a next-generation solution in the non-volatile memory (NVM) market. This development follows prior successes and positions the company for accelerated commercialisation and industry impact.

Weebit Nano secures a major licensing deal with onsemi, positioning its ReRAM technology for accelerated commercialisation and industry impact in the non-volatile memory market.

02/01/2025

The past year has been transformative for BrainChip Holdings (ASX: BRN), the global leader in neuromorphic computing. Through cutting-edge technological advancements, strategic partnerships, and a strong financial foundation, the company is carving a niche in the growing field of edge AI. As artificial intelligence increasingly reshapes industries, BrainChip's innovative solutions are poised to capture a significant share of this evolving market.

BrainChip Holdings advances neuromorphic computing with Akida platform, securing key partnerships and expanding applications across automotive, healthcare, IoT, and defense sectors.

31/12/2024

Audeara (ASX: AUA), a pioneer in tailored hearing solutions, closed out 2024 on a high note, achieving several milestones that have laid a robust foundation for an ambitious 2025. With a focus on growth in the Asia-Pacific region, key partnerships, and expanding its innovative product portfolio, the company is poised for a transformative year.

Audeara Limited plans global expansion in 2025, emphasizing Asia-Pacific growth, innovative product launches, and strategic partnerships to revolutionize hearing health.

28/12/2024

Memphasys - Reproductive Biotechnology (ASX: MEM), a biotechnology innovator in the reproductive health sector, has laid a robust foundation for success in 2024. Advancements in its flagship Felix™ System, expanding global partnerships, and the development of its oxidative stress measurement system set the stage for a breakthrough 2025. The coming year will see the company focus on achieving regulatory milestones, entering lucrative markets, and commercialising its cutting-edge technologies.

https://hubs.li/Q030LgR_0🚀

Memphasys (ASX: MEM) gears up for global expansion in 2025 with innovative reproductive technologies and strategic partnerships, targeting lucrative markets and achieving regulatory milestones.

28/12/2024

Memphasys has launched a bovine study using the RoXsta™ antioxidant system to explore links between oxidative stress and reproductive performance. Blood analysis begins January, with results expected February 2025.

27/12/2024

MTM Critical Metals (ASX: MTM) has solidified its position as a leader in critical metals recovery and processing with a banner year in 2024. Through innovative technology, strategic partnerships, and substantial financial backing, the company has laid the groundwork for a transformative impact on the global supply chain for critical and precious metals. The year’s achievements demonstrate MTM’s dual focus on technological disruption and commercialisation, underscoring its role in reshoring critical metals processing capabilities to the United States.

MTM Critical Metals leads in critical metals recovery with innovative technology, strategic partnerships, and strong financial backing, reshoring processing capabilities to the U.S. for a transformative impact.

27/12/2024

MTM Critical Metals (ASX: MTM) has solidified its position as a leader in critical metals recovery and processing with a banner year in 2024. Through innovative technology, strategic partnerships, and substantial financial backing, the company has laid the groundwork for a transformative impact on the global supply chain for critical and precious metals. The year’s achievements demonstrate MTM’s dual focus on technological disruption and commercialisation, underscoring its role in reshoring critical metals processing capabilities to the United States.

MTM Critical Metals: Pioneering a New Era in Critical Metals Recovery

MTM Critical Metals leads in critical metals recovery with innovative technology, strategic partnerships, and strong financial backing, reshoring processing capabilities to the U.S. for a transformative impact.

23/12/2024

MTM Critical Metals Secures $7.5M Placement, Cornerstoned By Pengana Capital and Terra Capital

MTM Critical Metals raises $7.5M in strategic placement, backed by institutional investors, to advance sustainable critical metals processing with revolutionary Flash Joule Heating technology.

20/12/2024

Little Green Pharma (ASX: LGP) is turning heads in the medicinal cannabis space with its proposed acquisition of Health House Australia Pty Ltd. In an ASX release dated 20 December 2024, the company unveiled its exclusive Letter of Intent (LOI) to purchase the cashflow breakeven distributor, marking a strategic leap toward vertical integration and enhanced market presence.

Little Green Pharma to acquire Health House, enhancing vertical integration and market reach in the medicinal cannabis industry.

20/12/2024

Reckon is investing $5.9 million in nQ Zebraworks to fuel its cloud-based billing and workflow automation growth for legal firms. This funding will support the company’s expansion through 2026, with promising sales and market growth potential.

Read more: https://hubs.li/Q030hZjP0

Reckon invests further in nQ Zebraworks for cloud growth

19/12/2024

Memphasys - Reproductive Biotechnology (ASX: MEM) has taken its cutting-edge reproductive biotechnology into the paddock, commencing a scoping study on its RoXsta™ antioxidant system in cattle breeding. This marks a bold expansion from the company’s expertise in human fertility into agricultural applications, aiming to tackle oxidative stress – a biochemical culprit that could be undermining bovine fertility and productivity.

Memphasys begins RoXsta™ trial to improve cattle fertility, targeting oxidative stress for better productivity, with potential large-scale applications in livestock management.

19/12/2024

The Tasmanian Government awards Alcore $1M to advance its groundbreaking industrial waste recycling technology, driving sustainability and innovation. Learn more: https://hubs.li/Q0307XLC0

Tasmanian Government funds ALCORE's innovative pilot plant with $1 million to recycle aluminium smelter waste, boosting sustainability and local industry.

17/12/2024

icetana AI secures its first Malaysian customer with a $465,000 three-year deal, expanding its footprint in Southeast Asia’s tech market. Learn more: https://hubs.li/Q02_TCzh0

icetana AI secures its first Malaysian customer in $465,000, three-year deal

17/12/2024

Control Bionics expands into the U.S. sports and Japanese rehabilitation markets, advancing assistive technology on a global scale. Learn more: https://hubs.li/Q02_TBWr0

Control Bionics Expands into U.S. Sports and Japanese Rehabilitation Markets

16/12/2024

When consumer GenAI platforms fall short for businesses, it’s crucial to turn to specialized solutions designed for enterprise needs. Learn why: https://hubs.ly/Q02_Jrh60

When consumer GenAI platforms won’t cut it for businesses

16/12/2024

Atturra solidifies its market leadership with the acquisition of Chrome Consulting, expanding its reach in digital transformation and enterprise solutions. Learn more: https://hubs.ly/Q02_Jcz60

Atturra Secures Market Leadership with Chrome Consulting Acquisition

16/12/2024

DigiCert forecasts a quantum leap in cybersecurity by 2025, highlighting advancements that will redefine digital trust and data protection. Learn more: https://hubs.ly/Q02_JsNy0

DigiCert Forecasts a Quantum Leap in Cybersecurity for 2025

16/12/2024

icetana AI secures a major three-year deal in Malaysia, expanding its footprint in the fast-growing Southeast Asian market. Learn more: https://hubs.ly/Q02_Jr190

icetana AI secures major three-year deal in Malaysia, tapping into growing southeast asian market